Prognostic value of the chemokine receptor CXCR4 and epithelial-to- mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue

Oral Oncology

Volumn 48, Issue 12, 2012, Pages 1263-1271

  Albert, Sébastien ^a,b   Hourseau, Muriel ^b   Halimi, Caroline ^a,b   Serova, Maria ^a,c   Descatoire, Véronique ^b   Barry, Béatrix ^b   Couvelard, Anne ^b   Riveiro, Maria Eugenia ^a   Tijeras Raballand, Annemilaï ^c   De Gramont, Armand ^c   Raymond, Eric ^a   Faivre, Sandrine ^a  

^a BEAUJON HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c AAREC Filia Research   (France)

Author keywords

CA9; CXCL12; CXCR4; E cadherin; Head and neck cancer; HIF 1; Oral cancer; SDF 1; Squamous cell carcinoma; Tongue; Vimentin

Indexed keywords

CARBONATE DEHYDRATASE IX; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; TUMOR MARKER; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 84869493476     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.06.010     Document Type: Article

References (60)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. C.G. Gourin, and R.H. Podolsky Racial disparities in patients with head and neck squamous cell carcinoma Laryngoscope 116 2006 1093 1106
3. D.M. Brizel, T. Schroeder, and R.L. Scher Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 349 353
4. D.M. Brizel, G.S. Sibley, L.R. Prosnitz, R.L. Scher, and M.W. Dewhirst Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
5. K.J. Laing, and C.J. Secombes Chemokines Dev Comp Immunol 28 2004 443 460
6. T. Takabayashi, N. Takahashi, M. Okamoto, H. Yagi, M. Sato, and S. Fujieda Lipopolysaccharides increase the amount of CXCR4, and modulate the morphology and invasive activity of oral cancer cells in a CXCL12-dependent manner Oral Oncol 45 2009 968 973
7. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550
8. C.C. Schimanski, R. Bahre, and I. Gockel Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4 Br J Cancer 95 2006 210 217
9. X. Sun, G. Cheng, and M. Hao CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression Cancer Metastasis Rev 29 2010 709 722
10. C.C. Bleul, M. Farzan, and H. Choe The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382 1996 829 833
11. A. Muller, B. Homey, and H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
12. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E.J. Oakeley, and W. Krek Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 425 2003 307 311
13. F. Balkwill The significance of cancer cell expression of the chemokine receptor CXCR4 Semin Cancer Biol 14 2004 171 179
14. M. Sabbah, S. Emami, and G. Redeuilh Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers Drug Resist Updat 11 2008 123 151
15. A. Satelli, and S. Li Vimentin in cancer and its potential as a molecular target for cancer therapy Cell Mol Life Sci 68 2011 3033 3046
16. A. Ghoul, M. Serova, and L. Astorgues-Xerri Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells Cancer Res 69 2009 4260 4269
17. M.M. Nijkamp, P.N. Span, I.J. Hoogsteen, A.J. van der Kogel, J.H. Kaanders, and J. Bussink Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients Radiother Oncol 99 2011 344 348
18. A. Coca-Pelaz, J.P. Rodrigo, and C. Suarez Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas Head Neck 34 2012 771 775
19. H. Hauswald, C. Simon, S. Hecht, J. Debus, and K. Lindel Long-term outcome and patterns of failure in patients with advanced head and neck cancer Radiat Oncol 6 2011 70
20. E. Lartigau, A.M. Le Ridant, and P. Lambin Oxygenation of head and neck tumors Cancer 71 1993 2319 2325
21. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nat Rev Cancer 11 2011 393 410
22. S.V. Ivanov, I. Kuzmin, and M.H. Wei Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes Proc Natl Acad Sci USA 95 1998 12596 12601
23. N.J. Beasley, C.C. Wykoff, and P.H. Watson Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density Cancer Res 61 2001 5262 5267
24. C.C. Wykoff, N.J. Beasley, and P.H. Watson Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 60 2000 7075 7083
25. D.J. Ceradini, A.R. Kulkarni, and M.J. Callaghan Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864
26. T. Schioppa, B. Uranchimeg, and A. Saccani Regulation of the chemokine receptor CXCR4 by hypoxia J Exp Med 198 2003 1391 1402
27. D. Zagzag, B. Krishnamachary, and H. Yee Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor Cancer Res 65 2005 6178 6188
28. D. Zagzag, Y. Lukyanov, and L. Lan Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion Lab Invest 86 2006 1221 1232
29. B.S. Carver, J. Tran, and A. Gopalan Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate Nat Genet 41 2009 619 624
30. W.M. Tilakaratne, and E.H. Nissanka-Jayasuriya Value of HIF-1alpha as an independent prognostic indicator in oral squamous cell carcinoma Expert Rev Mol Diagn 11 2011 145 147
31. A.W. Eckert, A. Schutze, M.H. Lautner, H. Taubert, J. Schubert, and U. Bilkenroth HIF-1alpha is a prognostic marker in oral squamous cell carcinomas Int J Biol Markers 25 2010 87 92
32. I.J. Hoogsteen, H.A. Marres, J. Bussink, A.J. van der Kogel, and J.H. Kaanders Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review Head Neck 29 2007 591 604
33. A.L. Harris Hypoxia-a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
34. Q.T. Le, N.C. Denko, and A.J. Giaccia Hypoxic gene expression and metastasis Cancer Metastasis Rev 23 2004 293 310
35. T. Ishikawa, K. Nakashiro, and S. Hara CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma Int J Oncol 28 2006 61 66
36. D.L. Ou, H.F. Chien, C.L. Chen, T.C. Lin, and L.I. Lin Role of twist in head and neck carcinoma with lymph node metastasis Anticancer Res 28 2008 1355 1359
37. M. Taki, K. Higashikawa, and S. Yoneda Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma Oncol Rep 19 2008 993 998
38. T. Onoue, D. Uchida, N.M. Begum, Y. Tomizuka, H. Yoshida, and M. Sato Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells Int J Oncol 29 2006 1133 1138
39. T. Yu, Y. Wu, J.I. Helman, Y. Wen, C. Wang, and L. Li CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway Mol Cancer Res 9 2012 161 172
40. C.T. Tan, C.Y. Chu, and Y.C. Lu CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway Carcinogenesis 29 2008 1519 1527
41. T.N. Hartmann, J.A. Burger, A. Glodek, N. Fujii, and M. Burger CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells Oncogene 24 2005 4462 4471
42. A. Janowska-Wieczorek, L.A. Marquez, A. Dobrowsky, M.Z. Ratajczak, and M.L. Cabuhat Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines Exp Hematol 28 2000 1274 1285
43. G.J. Samara, D.M. Lawrence, and C.J. Chiarelli CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma Cancer Lett 214 2004 231 241
44. M. Ueda, T. Shimada, and Y. Goto Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma Auris Nasus Larynx 37 2010 488 495
45. A. Almofti, D. Uchida, and N.M. Begum The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma Int J Oncol 25 2004 65 71
46. C. Zheng, R. Ge, M. Ge, and X. Sun The expression and relationship of CXCR4 and microvessel density in laryngeal squamous cell carcinoma Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 25 2011 123 126
47. H.H. Oliveira-Neto, E.T. Silva, and C.R. Leles Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas Tumour Biol 29 2008 262 271
48. D. Yin, and Z. Gao Expression and clinical significance of chemokine receptor 4 in oral squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 25 2007 392 395
49. X. Meng, L. Wuyi, X. Yuhong, and C. Xinming Expression of CXCR4 in oral squamous cell carcinoma: correlations with clinicopathology and pivotal role of proliferation J Oral Pathol Med 39 2010 63 68
50. Y.X. Sun, J. Wang, and C.E. Shelburne Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo J Cell Biochem 89 2003 462 473
51. R.J. Phillips, M.D. Burdick, M. Lutz, J.A. Belperio, M.P. Keane, and R.M. Strieter The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases Am J Respir Crit Care Med 167 2003 1676 1686
52. D. Uchida, T. Onoue, and Y. Tomizuka Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma Mol Cancer Res 5 2007 685 694
53. J.I. Lee, B.H. Jin, M.A. Kim, H.J. Yoon, S.P. Hong, and S.D. Hong Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 678 684
54. F. Clatot, J.M. Picquenot, and O. Choussy Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma Oral Oncol 47 2011 1062 1068
55. C.B. Delilbasi, M. Okura, S. Iida, and M. Kogo Investigation of CXCR4 in squamous cell carcinoma of the tongue Oral Oncol 40 2004 154 157
56. J.P. Spano, F. Andre, and L. Morat Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome Ann Oncol 15 2004 613 617
57. K. Shibuta, M. Mori, K. Shimoda, H. Inoue, P. Mitra, and G.F. Barnard Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation Jpn J Cancer Res 93 2002 789 797
58. M. Kato, J. Kitayama, S. Kazama, and H. Nagawa Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma Breast Cancer Res 5 2003 R144 R150
59. N. Wang, Q.L. Wu, and Y. Fang Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome J Transl Med 3 2005 26
60. L. Wang, Z. Wang, B. Yang, Q. Yang, and Y. Sun CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma Oncol Rep 22 2009 1333 1339